JOHNSON KENNETH ERLAND

PrivateCIK: 1743774
Location

CHICAGO, IL

JOHNSON KENNETH ERLAND (See Remarks) received a stock award from XERIS BIOPHARMA HOLDINGS, INC.

Compensation award — not an open‑market transaction. Less informative as a directional signal.

A · 2 awards
InsiderJOHNSON KENNETH ERLANDCIK 1743774
Officer· See Remarks
Since Oct 2021
+322.08K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
8
Total transactions
322.08K acquired
Non-Derivative Transactions2

Common Stock

Direct
A · Award

Shares

+11.25K

Price / share

Trade value

% of position

New position
10/5/2021
0.0011.25K

Common Stock

Direct
A · Award

Shares

+78.33K

Price / share

Trade value

% of position

696.3%
10/5/2021
11.25K89.58K
Total

Net shares

+89.58K

Net value

$0.00

Derivative Transactions6

Stock Option (Right to Buy)

Direct
A · Award
Converts to

Common Stock

33.69K shares

Shares

+33.69K

Strike price

1.55

Held after

33.69K

Exercisable

10/5/2021

Stock Option (Right to Buy)

Direct
A · Award
Converts to

Common Stock

5.28K shares

Shares

+5.28K

Strike price

1.55

Held after

5.28K

Exercisable

10/5/2021

Stock Option (Right to Buy)

Direct
A · Award
Converts to

Common Stock

39.63K shares

Shares

+39.63K

Strike price

5.93

Held after

39.63K

Exercisable

10/5/2021

Stock Option (Right to Buy)

Direct
A · Award
Converts to

Common Stock

21.40K shares

Shares

+21.40K

Strike price

19.00

Held after

21.40K

Exercisable

10/5/2021

Stock Option (Right to Buy)

Direct
A · Award
Converts to

Common Stock

32.50K shares

Shares

+32.50K

Strike price

13.88

Held after

32.50K

Exercisable

10/5/2021

Stock Option (Right to Buy)

Direct
A · Award
Converts to

Common Stock

100K shares

Shares

+100K

Strike price

3.94

Held after

100K

Exercisable

10/5/2021
JOHNSON KENNETH ERLAND — Insider Transaction (Form 4) Filed Oct 5, 2021 | Finecho